Literature DB >> 16914595

The risk of fractures in postmenopausal women with primary hyperparathyroidism.

Simona De Geronimo1, Elisabetta Romagnoli, Daniele Diacinti, Emilio D'Erasmo, Salvatore Minisola.   

Abstract

OBJECTIVE: To evaluate the prevalence of vertebral (vFr) and non-vertebral (nvFr) fractures in postmenopausal women with primary hyperparathyroidism (PHPT).
MATERIALS AND METHODS: We studied 98 patients with PHPT, divided into 'mild' (M, n = 25) and 'non-mild' (NM, n = 73) sub-groups, according to recently published guidelines (2002), and 89 healthy women (C) matched for age, years since menopause and body mass index. vFr was evaluated according to a visual semiquantitative method; bone mineral density (BMD) at the lumbar spine (LS), and femoral sites (femoral neck, FN and total femur, FT) was measured by dual energy X-ray absorptiometry. Volumetric BMD of the third lumbar vertebra (vBMDL3) was also calculated.
RESULTS: The prevalence of vFr was significantly higher (P < 0.001) in both M and NM PHPT patients compared with C; this prevalence did not differ between M and NM patients. BMD was significantly lower (P < 0.05) in NM patients compared with both C and M patients. BMD at LS in M patients was also significantly higher with respect to C. Similar results were also obtained for vBMDL3; in M patients, vBMDL3 was also significantly higher compared to C. When M and NM patients were subdivided according to the presence or lack of vFr, no difference was found between fractured and unfractured patients for either BMD or vBMDL3 values.
CONCLUSIONS: The risk of vFr is higher in postmenopausal patients with mild PHPT even if BMD appears well preserved. This finding suggests that other factors, such as bone quality, seem to be relevant in determining fracture risk, especially when gonadal function is lacking.

Entities:  

Mesh:

Year:  2006        PMID: 16914595     DOI: 10.1530/eje.1.02225

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  22 in total

1.  Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

Authors:  Cristiana Cipriani; Federica Biamonte; Aline G Costa; Chiyuan Zhang; Piergianni Biondi; Daniele Diacinti; Jessica Pepe; Sara Piemonte; Alfredo Scillitani; Salvatore Minisola; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2015-02-03       Impact factor: 5.958

2.  Hip fracture risk in patients with a diagnosis of pernicious anemia.

Authors:  Nathan A Merriman; Mary E Putt; David C Metz; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

3.  Bone disease in primary hyperparathyrodism.

Authors:  Claudio Marcocci; Luisella Cianferotti; Filomena Cetani
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-10       Impact factor: 5.346

Review 4.  Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis.

Authors:  H Ejlsmark-Svensson; L Rolighed; T Harsløf; L Rejnmark
Journal:  Osteoporos Int       Date:  2021-02-01       Impact factor: 4.507

5.  Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.

Authors:  M D Walker; I Saeed; J A Lee; C Zhang; D Hans; T Lang; S J Silverberg
Journal:  Osteoporos Int       Date:  2016-05-19       Impact factor: 4.507

6.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

7.  Trabecular bone microarchitecture in mild primary hyperparathyroidism.

Authors:  L Dalle Carbonare; P Ballanti; F Bertoldo; M T Valenti; B Giovanazzi; S Giannini; G Realdi; V Lo Cascio
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

8.  Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study.

Authors:  Cristiana Cipriani; Vincenzo Carnevale; Federica Biamonte; Sara Piemonte; Jessica Pepe; Luciano Nieddu; John P Bilezikian; Salvatore Minisola
Journal:  Eur J Endocrinol       Date:  2014-07-11       Impact factor: 6.664

9.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

Review 10.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.